发明名称 PRODUCTION OF A HCMV BASED VACCINE IN HUMAN AMNIOCYTE CELL LINES
摘要 <p>The present invention relates to a method for the production of human Cytomegalovirus (HCMV) particles, the method including the steps of: (a) contacting and thereby infecting a permanent human amniocyte cell with HCMV, (b) incubating the amniocyte cell, (c) allowing expression of HCMV particles, and (d) isolating of the HCMV particles, wherein the permanent human amniocyte cell expresses the adenoviral gene products E1A and E1B and wherein the amniocyte cells are cultured in serum free medium. Furthermore, the present invention relates to HCMV particles produced by the method of the present invention as well as to a HCMV based vaccine comprising the HCMV particles, the use of the HCMV particles for use in the preparation of a HCMV based vaccine and the HCMV particles for use in the preparation of a therapeutic or diagnostic agent for the prevention or treatment of a HCMV related disease.</p>
申请公布号 WO2014060594(A1) 申请公布日期 2014.04.24
申请号 WO2013EP71887 申请日期 2013.10.18
申请人 CEVEC PHARMACEUTICALS GMBH 发明人 SCHIEDNER, GUDRUN;PLACHTER, BODO
分类号 C07K14/005;C12N7/00;C12N7/02;C12N7/04;C12N15/86 主分类号 C07K14/005
代理机构 代理人
主权项
地址